SGRD-UIZ-C 
William J. Gartland, Jr., Ph.D. 
9 June 1982 
points out. The Department has in earlier correspondence agreed to comply, 
both internally and through contract with established NIH Guidelines. 
The military medical DoD Interest in recombinant DNA technology is directly 
related to the development of means and methods for the prevention, diagnosis, 
or treatment of disease. Such interests are, or will be, targeted toward 
improved vaccines, new modalities of therapy or prophylaxis, and/or detection 
devices for a variety of organism identification and diagnostic purposes. Non- 
medical military interests cover areas of marine fouling problems; materials 
and polymer engineering; and fuels and lubricant potential, none of which 
have any relationship to biological weapons. 
We agree with the proposed changes by ACDA to bring the proposal to the Guidelines 
into closer alignment with the Convention which is the basic instrument of 
national policy. 
WILLIAM R. BEISEL, M.D. 
DoD Representative Federal Interagency 
Advisory Connittee on Recombinant DNA 
Research 
2 
[ 789 ] 
